New Delhi: With China’s National Medical Products Administration on Sunday giving a nod to CanSino’s Ad5-nCoV for emergency use as a booster dose, China has become the first country to approve a needle-free, inhaled version of a COVID-19 vaccine, news agency Bloomberg reported quoted an official statement.
China’s National Medical Products Administration approved CanSino’s Ad5-nCoV for emergency use as a booster vaccine, the company said in a statement to the Hong Kong Stock Exchange on Sunday.
Bhubaneswar: After two years, Naba Das' assassination in broad daylight has again grabbed headlines with…
Kolkata: A tiger from Jharkhand appears to be following the path taken by tigress Zeenat…
New Delhi: The Supreme Court on Monday halted criminal proceedings against Lok Sabha LoP and…
Mumbai: The courtroom in Bandra, where a Bangladeshi man arrested for allegedly attacking actor Saif…
Khurda: A 14-year-old boy was killed and his mother critically injured after being attacked by…
Bhubaneswar: With cold wave conditions sweeping Odisha, the night temperature plummeted further to 4 degree…
This website uses cookies.